ACM Research, Inc. (ACMR) Company Overview

ACM Research, Inc. is a Nasdaq-listed semiconductor capital-equipment supplier whose operating center of gravity is in mainland China. The company designs, manufactures, installs, and services tools used to clean, plate, deposit, heat-treat, coat, develop, and package semiconductor wafers and panels. Its official company overview describes a global wafer-fabrication-equipment business serving integrated-circuit manufacturing, compound semiconductors, wafer manufacturing, and advanced packaging.

Which production steps and customers does it serve?

ACM's original specialty is wet cleaning, where its SAPS, TEBO, and Tahoe technologies target particle removal, damage-free cleaning, and lower chemical consumption. The portfolio has expanded into electrochemical plating, vertical furnaces, plasma-enhanced chemical vapor deposition, photoresist track systems, stress-free polishing, and wafer- and panel-level packaging equipment. Those tools are sold mainly to foundries, memory manufacturers, integrated device manufacturers, wafer makers, and outsourced semiconductor assembly and test companies.

Why does the company matter in semiconductor equipment?

ACM matters because it is attempting to move from a cleaning-tool specialist into a broader process-equipment vendor. In the 2025 Form 10-K, management estimated that its product portfolio addresses multiple adjacent equipment markets, including approximately $7.3 billion for wafer cleaning, $5.3 billion for PECVD, $3.0 billion for track, $2.6 billion for furnace, and $1.5 billion for ECP. These are management estimates, not reported market shares, but they explain the strategic logic: each successful product qualification increases ACM's potential content per fab and reduces dependence on one equipment category.

ACM earns most revenue from selling capital equipment. It also generates smaller recurring revenue from services and spare parts. A repeat tool that has already been accepted by a customer can generally be recognized as revenue upon delivery. A first tool, however, may sit at the customer's facility for an extended evaluation period before acceptance. The company says an evaluation can last 24 months or longer, so shipments lead revenue and finished-goods inventory can include equipment physically located at customer sites.

How is the revenue mix changing?

Cleaning remained the largest category in FY2025, but the Q1 2026 mix changed sharply. Cleaning-related revenue fell 5.5% year over year to $122.5 million in Q1 2026, while ECP, furnace, and other technologies rose 204.9% to $84.2 million. Advanced packaging, services, and spares increased 62.0% to $24.5 million. That shift is strategically encouraging because it shows product diversification, but it also affects gross margin because different tools carry different economics.

Why are shipments and acceptance as important as bookings?

In Q1 2026, repeat-tool shipments were $96.9 million and first-tool shipments were $143.8 million. The large first-tool component signals a wide product-evaluation pipeline, but it is not equivalent to recognized revenue. At March 31, 2026, $119.5 million of finished goods consisted of first tools at customer sites awaiting acceptance. For analysis, shipments indicate commercial activity; acceptance converts that activity into reported revenue and cash-collection potential.

The freshest completed reporting period is the quarter ended March 31, 2026. ACM's Q1 2026 earnings release reported strong revenue and operating-income growth, but lower attributable net income and negative free cash flow. That combination captures the current model: product diversification is accelerating, while inventory, receivables, qualification timing, and global expansion absorb cash.

Where did operating leverage appear?

Q1 2026 gross profit was $107.2 million, up 29.9%, while operating expenses increased 25.2% to $71.1 million. Operating expenses declined to 30.7% of revenue from 32.9% in Q1 2025, allowing GAAP operating margin to improve to 15.6% from 15.0%. Research and development expense reached $36.5 million in Q1 2026, equal to 15.8% of revenue. This is meaningful operating leverage, but the 1.5-percentage-point gross-margin decline shows that mix can offset scale benefits.

Why did net income and cash flow lag revenue?

Other expense included a $9.5 million foreign-exchange loss in Q1 2026, compared with a $0.6 million loss in Q1 2025. Net income attributable to non-controlling interests rose to $8.9 million from $4.6 million because ACM does not own all of ACM Shanghai. Cash conversion was weaker still: inventories used $29.5 million of cash, accounts receivable used $8.3 million, accounts payable declined by $14.3 million, customer advances declined by $20.6 million, and deferred revenue declined by $6.4 million during Q1 2026.

ACM's history is useful only when it explains the present model: a U.S.-listed parent, a separately listed Chinese operating subsidiary, a large mainland manufacturing base, and an effort to qualify more products with global customers.

1. 1998
   ACM Research was founded in California to supply semiconductor capital equipment. Founder-led technical direction remains central to governance and product strategy.
2. 2005
   ACM Shanghai was formed and became the principal operating subsidiary, establishing the China-centered cost, customer, talent, and regulatory profile that still defines the company.
3. 2017
   ACMR Class A shares began trading on Nasdaq, providing U.S. public-market access while preserving a dual-class voting structure.
4. 2021
   ACM Shanghai completed its STAR Market listing on November 18, 2021. The listing added local capital access but introduced non-controlling interests and potential parent-subsidiary conflicts.
5. 2025
   ACM Shanghai raised approximately $623.0M net in a private offering for R&D, capital expenditure, and working capital; ACM Research's ownership fell to 74.6% at December 31, 2025.
6. 2026
   The company launched the ACM Planetary Family, shipped its first PECVD SiCN system, advanced the Lingang mini-line, and raised approximately $150M net at the U.S. parent for global expansion.

What did the Lingang mini-line change?

The June 2026 investor-relations record explains that the Lingang mini-line lets ACM validate processes and tune parameters before equipment reaches a customer's fab. That can shorten qualification, reduce outsourced testing, and improve particle-control and stability work across cleaning, plating, track, furnace, and PECVD tools. The first PECVD SiCN system used this pre-validation pathway before shipment in April 2026.

ACM's potential moat is not simply “technology.” It is the combination of proprietary process methods, customer qualification, customization, field support, a growing installed base, and the ability to reuse platforms across adjacent process steps. SAPS alternates megasonic phases for cleaning uniformity; TEBO targets damage-free cleaning of delicate patterned wafers; Tahoe reduces sulfuric-acid and hydrogen-peroxide consumption; Ultra ECP addresses plating uniformity; and newer furnace, track, and PECVD systems extend the same customer relationships into more of the fab.

What resources could be difficult to replicate?

Where is the moat still unproven?

The newer furnace, PECVD, and track platforms were still at earlier stages of evaluation and adoption in the 2025 filing. Large incumbents can bundle tools, finance more R&D, use broader service networks, and leverage longer customer relationships. ACM therefore has a credible resource base but not an equally established position in every category. Researchers should separate “addressable market” from “qualified production share.” The relevant evidence is repeat orders, accepted first tools, stable margins, and revenue generated outside cleaning—not product announcements alone.

The official filing names Lam Research, NAURA Technology, SCREEN Holdings, SEMES, Tokyo Electron, and Kokusai Semiconductor Equipment as principal competitors in cleaning, plating, and furnace markets. For PECVD and track, ACM also identifies Applied Materials and Suzhou Jingtuo. Rivalry is intense because chipmakers place a premium on uptime, yield, installed-base support, and process history. A customer may prefer an incumbent even when a new tool offers attractive specifications.

How should students interpret market position?

ACM sits between a niche specialist and a global multi-product incumbent. Its China scale and differentiated wet-processing technologies are established assets, while overseas qualification and newer dry-processing products remain the main proof points. The company's May 2026 investor presentation shows sales, service, development, and production activity across the United States, Europe, China, Korea, and other Asian markets, but financial disclosure still shows that global diversification is at an early stage.

The balance sheet is liquid, but cash generation is less straightforward than the headline cash balance. At March 31, 2026, cash and cash equivalents were $872.3 million, restricted cash was $21.9 million, and short-term time deposits were $358.2 million. Total borrowings were $328.1 million, comprising $94.0 million of short-term borrowings, $13.3 million of current long-term debt, and $220.9 million of long-term borrowings. The company's Q1 2026 net-cash measure was $924.2 million.

What does the balance sheet protect, and what does it not protect?

Liquidity gives ACM room to fund R&D, inventory, facilities, and overseas support without depending solely on current operating cash flow. It does not eliminate acceptance risk or the possibility that cash remains trapped or less accessible across legal entities and jurisdictions. Mainland China rules require reserve appropriations and can restrict dividends and foreign-exchange transfers from ACM Shanghai to the U.S. parent.

Why is working capital the key financial tension?

FY2025 net income was $121.9 million, yet operating cash flow was negative $10.3 million and company-defined free cash flow was negative $67.1 million. During FY2025, accounts receivable increased by $116.1 million, inventory increased by $108.2 million, and customer advances declined by $60.8 million. Q1 2026 repeated the pattern. For a DCF, revenue growth should not automatically be treated as cash growth; analysts need explicit assumptions for receivable days, inventory turns, customer advances, qualification timing, and capex.

ACM has Class A shares with one vote per share and Class B shares with twenty votes per share. The latest 2026 proxy statement reported 61,223,064 Class A shares and 4,991,808 Class B shares outstanding on April 13, 2026, representing 161,059,224 total votes. This means Class B represented only 7.5% of economic shares before considering options, yet approximately 62.0% of the voting power.

How concentrated is founder influence?

Founder David Wang can exercise decisive influence over director elections, compensation governance, capital raising, and strategic transactions even though outside investors own most economic shares. That can support a long R&D horizon, but it weakens the ability of Class A investors to change direction. The board had four nominees in the 2026 proxy, three of whom qualified as independent, and the company reported four board meetings and seven standing-committee meetings during 2025.

What does ACM Shanghai's separate listing add?

ACM Shanghai is publicly traded on the STAR Market and was 74.6% owned by ACM Research at December 31, 2025. Its separate shareholders, board, officers, disclosure requirements, and capital-raising options create a second governance layer. Success at ACM Shanghai benefits the consolidated group, but additional subsidiary issuance can increase non-controlling interests and reduce the share of future economics attributable to ACMR. Parent-company cash, subsidiary cash, consolidated cash, and voting control should therefore be analyzed separately.

The upside case depends on converting a large first-tool pipeline into repeat orders, expanding ECP and advanced packaging, qualifying furnace, PECVD, and track systems, and building meaningful revenue outside mainland China. In June 2026, ACM Shanghai said Q1 newly signed orders increased 65% year over year and ECP represented approximately 30% of year-to-date newly signed orders. Management also expected delivery of more than 20 low-, medium-, and high-temperature sulfuric-acid cleaning systems during 2026.

What are the most material operating and regulatory risks?

How should opportunity and risk be connected?

The same factors often sit on both sides of the analysis. More first tools create future revenue opportunity but consume inventory and delay cash. A larger Lingang footprint can accelerate qualification but raises fixed costs and capex. China semiconductor investment creates demand but also geopolitical, export-control, currency, audit, and fund-transfer exposure. The May 2026 registered direct offering supplies parent-level capital for global expansion, but it increased Class A shares by 2,884,615 at $52.00 per share.

ACM is not well understood through a simple revenue multiple. Its valuation depends on whether product breadth becomes durable repeat revenue, whether gross margin remains inside management's long-term 42%-48% range, and whether accounting profit converts into cash after inventory, receivables, and capex. The analysis must also separate consolidated earnings from earnings attributable to ACM Research because ACM Shanghai has outside shareholders.

Which DCF drivers deserve explicit assumptions?

What should researchers monitor next?